297142-55-3Relevant articles and documents
MAGL inhibitor, preparation method and application
-
Paragraph 0015-0018, (2020/08/30)
The invention belongs to the field of medicines, and relates to a compound and a pharmaceutically acceptable salt thereof, a preparation method thereof, a composition containing the compound or the salt, and their use for the treatment of MAGL-mediated diseases and disorders (including, for example, pain, inflammatory disorders, traumatic brain injury, depression, anxiety, Alzheimer's disease, metabolic disorders, stroke or cancer, etc).